Retinoids with retinoid receptor antagonistic activity, pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, have been found efficacious in treating T-helper cell type 2 (Th2)-mediated immune diseases, such as immunoglobulin E (IgE)-mediated allergic diseases.

Retinoids con la actividad antagónica del receptor del retinoid, farmacéutico sales aceptables y farmacéutico ésteres hydrolyzable aceptables de eso, se ha encontrado eficaz en tratar el tipo 2 (enfermedades inmunes de la célula del T-ayudante de Th2)-mediated, tales como inmunoglobulina E (enfermedades alérgicas IgE)-mediadas.

 
Web www.patentalert.com

< X-salizer an exerciser for the lungs

< Liquid dispensing apparatus and methods

> Tyrosine derivatives with anti-leukotrienen activity

> Metered dose inhaler for albuterol

~ 00082